Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

8.99
Delayed Data
As of Aug 28
 +0.32 / +3.69%
Today’s Change
2.31
Today|||52-Week Range
14.40
+77.32%
Year-to-Date

Today’s Trading

Previous close8.67
Today’s open8.56
Day’s range8.50 - 9.29
Volume3,617,452
Average volume (3 months)3,711,467
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+53.03%
Earnings growth (this year)-184.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.63%
P/E ratioNM
Price/Sales373.44
Price/Book27.75

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.07+0.67%
CLLSCellectis SA+0.51+1.56%
DVAXDynavax Technologies...+1.31+4.60%
RGENRepligen Corp-0.09-0.26%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$1.4M
Annual profit (last year)-$31.8M
Net profit margin-2,314.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers